Management of Epistaxis in the Elderly
Introduction to Epistaxis Management
- The American Academy of Otolaryngology-Head and Neck Surgery recommends oxymetazoline as a first-line therapy for epistaxis in all age groups, including the elderly, achieving bleeding control in 65-75% of cases 1, 2
Epidemiology and Risk Factors
- Elderly patients aged 85+ are 3.24 times more likely to present to the emergency department with epistaxis compared to those under 65 3, 4, 5, 6
- 33% of elderly epistaxis patients have hypertension, and 15% are on long-term anticoagulation 5, 6
Proper Administration Technique
- Apply oxymetazoline 0.05% (Afrin) as 2 sprays per nostril directly to the bleeding site, followed by firm, sustained compression of the soft lower third of the nose for a full 5-10 minutes without interruption 1, 8
- Phenylephrine nasal spray is an acceptable alternative vasoconstrictor 5, 1
Critical Safety Warnings for Elderly Patients
- Never use oxymetazoline continuously for more than 3-5 days due to risk of rhinitis medicamentosa (rebound congestion) and worsening mucosal damage 1, 2
- Vasoconstrictors can cause systemic cardiovascular complications in patients with hypertension, cardiovascular disease, or glaucoma 1
Essential Prevention Strategy
- Apply nasal saline spray or gel 2-4 times daily to maintain nasal moisture, resolving up to 65% of recurrent epistaxis cases 2, 8
- Continue moisturization even after bleeding resolves to prevent recurrence 1, 2
Special Considerations in the Elderly
- The 30-day all-cause mortality rate in elderly patients with posterior epistaxis is 3.4%, underscoring the importance of effective initial management 3, 5, 6
- Do not aggressively lower blood pressure during active epistaxis, as this can cause end-organ ischemia 8